Sava Infond D.O.O. Novo Nordisk A S Put Options Transaction History
Sava Infond D.O.O.
- $566 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NVO
# of Institutions
1,860Shares Held
333MCall Options Held
6.55MPut Options Held
7.8M-
Jennison Associates LLC19.9MShares$1.63 Billion1.06% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.17 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.17 Billion0.14% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.06 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.03 Billion0.44% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $185B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...